Vasopressin V1a and V1b receptors: from molecules to physiological systems (Q26823378)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Vasopressin V1a and V1b receptors: from molecules to physiological systems (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Hiroshi Nonoguchi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Kazuaki Nakamura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Nobuaki Egashira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Masami Hiroyama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Akito Tanoue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

1 reference

1 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

published in

Physiological Reviews

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

92

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

1813-1864

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Gating and habituation of the startle reflex in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin innervation of the mouse (Mus musculus) brain and spinal cord

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Association between a vasopressin receptorAVPR1A promoter region microsatellite and eating behavior measured by a self-report questionnaire (Eating Attitudes Test) in a family-based study of a nonclinical population

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Induction of Taurocholate Release from Isolated Rat Hepatocytes in Suspension by α-Adrenergie Agents and Vasopressin: Implications for Control of Bile Salt Secretion

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin directly closes ATP-sensitive potassium channels evoking membrane depolarization and an increase in the free intracellular Ca2+ concentration in insulin-secreting cells.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Acylcarnitine metabolism during fasting and after refeeding.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Central nervous system effects of the neurohypophyseal hormones and related peptides

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Baroreceptor regulation of vasopressin and renin secretion: low-pressure versus high-pressure receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The neurohypophysial endocrine regulatory cascade: precursors, mediators, receptors, and effectors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Protective effect of the V1a receptor antagonist SR49059 on brain edema formation following middle cerebral artery occlusion in the rat.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Molecular pharmacology of human vasopressin receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin regulates adrenal functions by acting through different vasopressin receptor subtypes.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

All three vasopressin receptor sub-types are expressed by small-cell carcinoma

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Safety, tolerability, and pharmacokinetics of SR 49059, a V1a vasopressin receptor antagonist, after repeated oral administration in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The modulation of aquaporin-4 by using PKC-activator (phorbol myristate acetate) and V1a receptor antagonist (SR49059) following middle cerebral artery occlusion/reperfusion in the rat.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Immunohistochemical localization of oxytocin and vasopressin in the adrenal glands of rat, cow, hamster and guinea pig.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Adrenal glomerulosa mitotic stimulation by posterior pituitary hormones

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Oxytocin-producing and vasopressin-producing eosinophils in the mouse spleen: immunohistochemical, immuno-electron-microscopic and in situ hybridization studies

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Localisation of oxytocin, vasopressin and parts of precursors in the human neonatal adrenal

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The neuroendocrine thymus. Abundant occurrence of oxytocin-, vasopressin-, and neurophysin-like peptides in epithelial cells

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Modulation of social memory in male rats by neurohypophyseal peptides.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin dependent adenylate cyclase in single segments of rabbit kidney tubule

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Repeated (isolation) stress increases tribulin-like activity in the rat

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Plasma Arginine Vasopressin in diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin antagonists

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The effects of vasopressin on acute kidney injury in septic shock.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Selective impairments in the stress response in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Intranephron localization and regulation of the V1a vasopressin receptor during chronic metabolic acidosis and dehydration in rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Provasopressin expression by breast cancer cells: implications for growth and novel treatment strategies.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Open-label randomized trial of the safety and efficacy of a single dose conivaptan to raise serum sodium in patients with traumatic brain injury

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Reduced Walker 256 carcinosarcoma growth in vasopressin-deficient Brattleboro rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Localization and characterization of vasopressin binding sites in the rat brain using an iodinated linear AVP antagonist

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Oxytocin receptors in the rat thymic gland

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Rapid stimulation, by vasopressin and adrenaline, of inorganic phosphate incorporation into phosphatidyl inositol in isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin rapidly stimulates phosphatidic acid-phosphatidylinositol turnover in rat anterior pituitary cells.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin: A potent growth factor in adrenal glomerulosa cells in culture

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Inhibition of centrally-evoked pressor responses by neurohypophyseal peptides and their fragments

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Thermoregulatory actions of centrally-administered vasopressin in the rat.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin receptor blockade in the anterior hypothalamus suppresses aggression in hamsters

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Testosterone facilitates aggression by modulating vasopressin receptors in the hypothalamus

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Oxytocin and arginine vasopressin stimulate steroid secretion by the isolated perfused rat adrenal gland

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Reflex control of magnocellular vasopressin and oxytocin secretion

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Modulation of insulin and glucagon secretion from the perfused rat pancreas by the neurohypophysial hormones and by desamino-D-arginine vasopressin (DDAVP)

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Evidence that endogenous arginine-vasopressin (AVP) is involved in the maintenance of the growth and steroidogenic capacity of rat adrenal zona glomerulosa

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Cell surface detection of membrane protein interaction with homogeneous time-resolved fluorescence resonance energy transfer technology

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Body water balance and body temperature in vasopressin V1b receptor knockout mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders?

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Enhanced glucose tolerance in the Brattleboro rat

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: A preliminary report.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Physiology and pathophysiology of the vasopressinergic system

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin in critical illness: sometimes even old players leave a lot to discover. Preface

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Preterm labour. Pharmacological prevention of prematurity

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Subchronic phencyclidine administration alters central vasopressin receptor binding and social interaction in the rat

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: therapeutic implications for schizophrenia

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Role of V1a vasopressin receptors in the control of aggression in Syrian hamsters

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of repeated restraint stress on hypothalamo-pituitary-adrenocortical function in vasopressin deficient Brattleboro rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Nonapeptide mechanisms of social cognition, behavior and species-specific social systems

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Enhanced reactivity to vasopressin in rat basilar arteries during vasospasm after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin V1A receptor enhances baroreflex via the central component of the reflex arc.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Impaired arginine-vasopressin-induced aldosterone release from adrenal gland cells in mice lacking the vasopressin V1A receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The vasopressin system--from antidiuresis to psychopathology

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Involvement of vasopressin in affective disorders

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Overview of cellular electrophysiological actions of vasopressin

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Altered lipid metabolism in vasopressin V1B receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Enhanced effect of neuropeptide Y on food intake caused by blockade of the V(1A) vasopressin receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Carnitine acyltransferases and their influence on CoA pools in health and disease

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Involvement of vasopressin V1b receptor in anti-anxiety action of SSRI and SNRI in mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The acute intoxicating effects of ethanol are not dependent on the vasopressin 1a or 1b receptors.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

AVP V1b selective antagonist SSR149415 blocks aggressive behaviors in hamsters

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Central actions of arginine vasopressin and a V1a receptor antagonist on maternal aggression, maternal behavior, and grooming in lactating rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A possible association between aldosterone response to vasopressin and circadian change of aldosterone in the patients with aldosterone-producing adenoma.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Arginine vasopressin V1a receptor antagonist impairs maternal memory in rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin: behavioral roles of an "original" neuropeptide

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Neonatal lesions of the ventral hippocampal formation disrupt neuroendocrine responses to auditory stress in the adult rat.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Association between arginine vasopressin 1a receptor (AVPR1a) promoter region polymorphisms and prepulse inhibition

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Age-dependent role of vasopressin in susceptibility of gastric mucosa to indomethacin-induced injury

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

San Antonio Vasopressin in Shock Symposium report

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Dimer-based model for heptaspanning membrane receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Principles: a model for the allosteric interactions between ligand binding sites within a dimeric GPCR.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Receptor heteromerization and drug discovery

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Structural insights into adrenergic receptor function and pharmacology

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Neuroendocrine mechanisms of innate states of attenuated responsiveness of the hypothalamo-pituitary adrenal axis to stress

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effect of photoperiod on vasopressin-induced aggression in Syrian hamsters

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Lipolysis and the integrated physiology of lipid energy metabolism

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin-deficient rats exhibit sensorimotor gating deficits that are reversed by subchronic haloperidol

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Plasma arginine vasopressin and motor activity in major depression

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Arginine-vasopressin in nucleus of the tractus solitarius induces hyperglycemia and brain glucose retention

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Physiological effects of vasopressin and atrial natriuretic peptide in the collecting duct.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Evidence that atypical vasopressin V(2) receptor in inner medulla of kidney is V(1B) receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Hypertrophic growth of cultured neonatal rat heart cells mediated by vasopressin V(1A) receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Oxytocin: who needs it?

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Chapter 14 Molecular pharmacology and modeling of vasopressin receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The parvocellular vasopressinergic system and responsiveness of the hypothalamic pituitary adrenal axis during chronic stress

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Molecular genetic studies of the arginine vasopressin 1a receptor (AVPR1a) and the oxytocin receptor (OXTR) in human behaviour: from autism to altruism with some notes in between

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Characterization of a novel and selective V1B receptor antagonist

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin binding sites in the central nervous system: distribution and regulation.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin: Mechanisms of Receptor Activation

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin vascular and reflex effects--a theoretical analysis

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Non-peptide arginine-vasopressin antagonists: the vaptans

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Social behavior functions and related anatomical characteristics of vasotocin/vasopressin systems in vertebrates

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin receptor 1a-mediated negative regulation of B cell receptor signaling.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Cloning of rat ARHGAP4/C1, a RhoGAP family member expressed in the nervous system that colocalizes with the Golgi complex and microtubules

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Arginine-vasopressin stimulates CRH and ACTH release by rat adrenal medulla, acting via the V1 receptor subtype and a protein kinase C-dependent pathway

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Olfactory bulb norepinephrine depletion abolishes vasopressin and oxytocin preservation of social recognition responses in rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of metabolic fragments of [Arg(8)]-vasopressin on nerve growth in cultured hippocampal neurons

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Plasma levels of arginine vasopressin elevated in patients with major depression

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Corticotropin releasing hormone, receptor regulation and the stress response.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

General introduction to vasopressin and oxytocin: structure/metabolism, evolutionary aspects, neural pathway/receptor distribution, and functional aspects relevant to memory processing

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Critical role of a subdomain of the N-terminus of the V1a vasopressin receptor for binding agonists but not antagonists; functional rescue by the oxytocin receptor N-terminus.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin accelerates protein synthesis in neonatal rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Central vasopressin V1a receptor activation is independently necessary for both partner preference formation and expression in socially monogamous male prairie voles

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A radio pulsar with an 8.5-second period that challenges emission models

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Corticotrophin releasing factor may be modulated vasopressin

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Phorbol esters and vasopressin stimulate DNA synthesis by a common mechanism

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin–neurophysin II precursor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Intracellular ATP directly blocks K+ channels in pancreatic B-cells

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Oligomerization of G-protein-coupled transmitter receptors.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Molecular cloning and expression of a rat V1a arginine vasopressin receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Structure and expression of a human oxytocin receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Molecular cloning of the receptor for human antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Multiple Sites of Vasopressin Synthesis in the Injured Brain

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Regulation of Na+ channels in the cortical collecting duct by AVP and mineralocorticoids

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin regulation of blood pressure and volume: findings from V1a receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Enhanced partner preference in a promiscuous species by manipulating the expression of a single gene

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Crystal structure of the human beta2 adrenergic G-protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A role for Rhesus factor Rhcg in renal ammonium excretion and male fertility

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

An intrinsic vasopressin system in the olfactory bulb is involved in social recognition

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

1 reference

7 January 2021

Time-resolved FRET between GPCR ligands reveals oligomers in native tissues.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Fatherhood affects dendritic spines and vasopressin V1a receptors in the primate prefrontal cortex

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The brattleboro rat displays a natural deficit in social discrimination that is restored by clozapine and a neurotensin analog

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Teaching old receptors new tricks: biasing seven-transmembrane receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Aquaporins in kidney pathophysiology

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Low sympathetic tone and obese phenotype in oxytocin-deficient mice.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Pharmacological characterization of F-180: a selective human V(1a) vasopressin receptor agonist of high affinity

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

G-protein-coupled receptor heteromers: function and ligand pharmacology

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Roles of G-protein-coupled receptor dimerization

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin V1b receptor knockout reduces aggressive behavior in male mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Anxious-retarded depression: relation with plasma vasopressin and cortisol

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Stimulation by vasopressin of glycogen breakdown and gluconeogenesis in the perfused rat liver

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The influence of vasopressin and related peptides on glycogen phosphorylase activity and phosphatidylinositol metabolism in hepatocytes

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Relationship between acid-soluble carnitine and coenzyme A pools in vivo

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Metabolic effects of vasopressin infusion in the starved rat. Reversal of ketonaemia

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Lack of vasopressin receptors in liver, but not in kidney, of ob/ob mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acet

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A second site of vasopressin action on [1-14C]oleate metabolism in isolated rat hepatocytes: increased formation of 14CO2

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin in Cardiovascular Control: Role of Circulating Vasopressin

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Systematic review: terlipressin in acute oesophageal variceal haemorrhage

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Osmoregulation of plasma vasopressin in diabetes mellitus with sustained hyperglycemia

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Thymic expression of neuroendocrine self-peptide precursors: role in T cell survival and self-tolerance

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Area postrema and sympathetic nervous system effects of vasopressin and angiotensin II.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Viral vector-mediated gene transfer of the vole V1a vasopressin receptor in the rat septum: improved social discrimination and active social behaviour

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Glucose dependency of arginine vasopressin-induced insulin and glucagon release from the perfused rat pancreas

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Placental transfer of SR49059 in the human dually perfused cotyledon in vitro

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Regulation of adrenocortical function by vasopressin

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Amelioration of Metabolic Acidosis with Fludrocortisone Therapy in Hyporeninemic Hypoaldosteronism

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Blood pressure in acute and chronic vasopressin excess: studies of malignant hypertension and the syndrome of inappropriate antidiuretic hormone secretion

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin versus norepinephrine infusion in patients with septic shock.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Prevention of preterm delivery

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Sex-specific influences of vasopressin on human social communication.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Variation in neural V1aR predicts sexual fidelity and space use among male prairie voles in semi-natural settings

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Brain vasopressin is an important regulator of maternal behavior independent of dams' trait anxiety

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin stimulation of mouse 3T3 cell growth

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Properties of rat anterior pituitary vasopressin receptors: relation to adenylate cyclase and the effect of corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Mutational analysis and molecular modeling of the nonapeptide hormone binding domains of the [Arg8]vasotocin receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A serine cluster prevents recycling of the V2 vasopressin receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Structure of the Rat V1a Vasopressin Receptor Gene and Characterization of Its Promoter Region and Complete cDNA Sequence of the 3′-End

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The human histidine decarboxylase promoter is regulated by gastrin and phorbol 12-myristate 13-acetate through a downstream cis-acting element

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Nitrosation of tryptophan residue(s) in serum albumin and model dipeptides. Biochemical characterization and bioactivity

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Transient phosphorylation of the V1a vasopressin receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The aquaporins, blueprints for cellular plumbing systems.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Novel form of lipolysis induced by leptin

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Disruption of adiponectin causes insulin resistance and neointimal formation

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The long and the short cycle. Alternative intracellular routes for trafficking of G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Identification of the binding sites of the SR49059 nonpeptide antagonist into the V1a vasopressin receptor using sulfydryl-reactive ligands and cysteine mutants as chemical sensors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Identification of amino acid residues that direct differential ligand selectivity of mammalian and nonmammalian V1a type receptors for arginine vasopressin and vasotocin. Insights into molecular coevolution of V1a type receptors and their ligands

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A novel C-terminal motif is necessary for the export of the vasopressin V1b/V3 receptor to the plasma membrane.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Mechanisms of cell-surface rerouting of an endoplasmic reticulum-retained mutant of the vasopressin V1b/V3 receptor by a pharmacological chaperone

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Pharmacological chaperone activity of SR49059 to functionally recover misfolded mutations of the vasopressin V1a receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Charged extracellular residues, conserved throughout a G-protein-coupled receptor family, are required for ligand binding, receptor activation, and cell-surface expression

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Protein kinase C regulates internal initiation of translation of the GATA-4 mRNA following vasopressin-induced hypertrophy of cardiac myocytes

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Systematic analysis of the entire second extracellular loop of the V(1a) vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Intrauterine pressure, ischemia markers, and experienced pain during administration of a vasopressin V1a receptor antagonist in spontaneous and vasopressin-induced dysmenorrhea

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Phencyclidine (PCP): a dangerous drug, but useful in schizophrenia research

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The effect of relcovaptan (SR 49059), an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Functional and pharmacological characterization of the first specific agonist and antagonist for the V1b receptor in mammals

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

THE PHYSIOLOGICAL EFFECTS OF EXTRACTS OF THE HYPOPHYSIS CEREBRI AND INFUNDIBULAR BODY.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Decreased susceptibility to salt-induced hypertension in subtotally nephrectomized mice lacking the vasopressin V1a receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Hypothalamic vasopressin release and hepatocyte Ca 2+ signaling during liver regeneration: an interplay stimulating liver growth and bile flow

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The vasopressin system: physiology and clinical strategies

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin pressor hypersensitivity in vasodilatory septic shock

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Pressor Responsiveness and Cardiovascular Reflex Activity in Spontaneously Hypertensive and Normotensive Rats During Vasopressin Infusion

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin and hypertension in man

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of arginine vasopressin on growth of rat cardiac fibroblasts: role of V1 receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Novel agents for the treatment of hyponatremia: a review of conivaptan and tolvaptan

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Complications and outcomes in chronic liver disease.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Oxytocin receptor-deficient mice developed late-onset obesity

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The discovery of novel vasopressin V1b receptor ligands for pharmacological, functional and structural investigations

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Homo- and hetero-dimeric complex formations of the human oxytocin receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A tubule cell line established from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The effect of vasopressin infusion on glucose metabolism in man

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Inositol phospholipid turnover and intracellular Ca2+ responses to thyrotrophin-releasing hormone, gonadotrophin-releasing hormone and arginine vasopressin in pituitary corticotroph and somatotroph adenomas.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors?

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Attenuated stress response to acute lipopolysaccharide challenge and ethanol administration in vasopressin V1b receptor knockout mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Pituitary-adrenal response to acute and repeated mild restraint, forced swim and change in environment stress in arginine vasopressin receptor 1b knockout mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Hypothalamic vasopressin and oxytocin mRNA expression in relation to depressive state in Alzheimer's disease: a difference with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Maternal behaviour is associated with vasopressin release in the medial preoptic area and bed nucleus of the stria terminalis in the rat

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Attenuated stress response to acute restraint and forced swimming stress in arginine vasopressin 1b receptor subtype (Avpr1b) receptor knockout mice and wild-type mice treated with a novel Avpr1b receptor antagonist

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The Vasopressin V1b Receptor Modulates Plasma Corticosterone Responses to Dehydration-Induced Stress

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Deficient sensorimotor gating after 6-hydroxydopamine lesion of the rat medial prefrontal cortex is reversed by haloperidol

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin released within the central amygdala promotes maternal aggression

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of SR 49059, an orally active V1a vasopressin receptor antagonist, on vasopressin-induced uterine contractions

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of lysine-vasopressin and oxytocin on central cardiovascular control

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Involvement of arginine vasopressin and V1b receptor in alcohol drinking in Sardinian alcohol-preferring rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Inhibitory effects of SR 49059 on oxytocin-and vasopressin-induced uterine contractions in non-pregnant women

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Association of vasopressin 1a receptor levels with a regulatory microsatellite and behavior

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin 1a receptor knockout mice have a subtle olfactory deficit but normal aggression

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Disruption of the vasopressin 1b receptor gene impairs the attack component of aggressive behavior in mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Mechanisms of action of CRF and other regulators of ACTH release in pituitary corticotrophs

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Pharmacology of oxytocin and vasopressin receptors in the central and peripheral nervous system.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Molecular biology of vasopressin receptors.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

On the Physiological Action of Extracts of Pituitary Body and certain other Glandular Organs: Preliminary Communication

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The origin of the glucose in the hyperglycaemia induced by pituitrin.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Hyperammonaemia in V1a vasopressin receptor knockout mice caused by the promoted proteolysis and reduced intrahepatic blood volume.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Insulin hypersensitivity in mice lacking the V1b vasopressin receptor.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

1 reference

7 January 2021

Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Differential coupling of the vasopressin V1b receptor through compartmentalization within the plasma membrane

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Oxytocin, vasopressin, and the neurogenetics of sociality

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effect of synthetic lysine vasopressin on adrenocortical secretion

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Crystal structure of rhodopsin: A G protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Synthesis, Transport, and Release of Posterior Pituitary Hormones

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin Exhibits a Rhythmic Daily Pattern in Cerebrospinal Fluid But Not in Blood

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

V₂ receptor-mediated autocrine role of somatodendritic release of AVP in rat vasopressin neurons under hypo-osmotic conditions.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Diagnosis and management of dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

On the presence of chromaffin cells in the adrenal cortex: their possible role in adrenocortical function

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Convulsive and hypothermic effects of vasopressin in the brain of the rat

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Glutamatergic mechanisms in schizophrenia

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Nephrogenic diabetes insipidus.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Attenuated stress-induced catecholamine release in mice lacking the vasopressin V1b receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Adrenalectomy enhances the insulin sensitivity of muscle protein synthesis

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Actions of neurohypophysial peptides on pancreatic hormone release

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effect of AVP and oxytocin on insulin release: involvement of V1b receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Role of the human V1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Proinflammatory role of vasopressin through V1b receptors in hapten-induced experimental colitis in rodents: implication in IBD.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin modulates liver regeneration in the Brattleboro rat

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Does vasopressin sustain blood pressure of normally hydrated healthy volunteers?

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Evidence for a vasodilatory effect of vasopressin in the conscious rat.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin stimulates the mobilization and metabolism of triacylglycerol in perfused rabbit hearts

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

L-NAME antagonizes vasopressin V2-induced vasodilatation in dogs

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effect of vasopressin on baroreflex control of lumbar sympathetic nerve activity and hindquarter resistance

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Glycogenolytic effect of vasopressin in the canine liver

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

EFFECT OF PITRESSIN ON LIPOLYSIS AND ON PHOSPHORYLASE ACTIVITY IN RAT ADIPOSE TISSUE

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Alcohol preference in mice lacking the Avpr1a vasopressin receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Control of renal medullary blood flow by vasopressin V1 and V2 receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin pressor receptor-mediated activation of HPA axis by acute ethanol stress in rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin receptor V1a regulates circadian rhythms of locomotor activity and expression of clock-controlled genes in the suprachiasmatic nuclei

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Axial heterogeneity of vasopressin-receptor subtypes along the human and mouse collecting duct.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Regulation of V2R transcription by hypertonicity and V1aR-V2R signal interaction

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Downregulation of vasopressin V2 receptor promoter activity via V1a receptor pathway

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin and oxytocin receptors coupled to Ca2+ mobilization in rat inner medullary collecting duct

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Minealocorticoid receptors and 11 beta-steroid dehydrogenase activity in renal principal and intercalated cells

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Electrophysiological study of luminal and basolateral vasopressin in rabbit cortical collecting duct.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Low pH stimulates vasopressin V2 receptor promoter activity and enhances downregulation induced by V1a receptor stimulation

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Role of L-glutamate in systemic AVP-induced hypothermia.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Arginine-vasopressin mediates central and peripheral glucose regulation in response to carotid body receptor stimulation with Na-cyanide.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin increases GABAergic inhibition of rat hypothalamic paraventricular nucleus neurons in vitro.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Role of vasopressin in cardiovascular regulation

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The oxytocin receptor system: structure, function, and regulation

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The hypothalamus and hypertension

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Evaluation of the secretory pattern of plasma arginine vasopressin in stroke patients.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Binding of the non-peptide vasopressin V1a receptor antagonist SR-49059 in the rat brain: an in vitro and in vivo autoradiographic study

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Suppression of adrenocorticotrophic hormone secretion by simultaneous antagonism of vasopressin 1b and CRH-1 receptors on three different stress models

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Repeated Stress-Induced Activation of Corticotropin-Releasing Factor Neurons Enhances Vasopressin Stores and Colocalization with Corticotropin-Releasing Factor in the Median Eminence of Rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Impaired histamine- and stress-induced secretion of ACTH and beta-endorphin in vasopressin-deficient Brattleboro rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin deficiency contributes to the vasodilation of septic shock

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Cardiovascular depression and stabilization by central vasopressin in rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin and blood pressure in humans

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Interaction of the sympathetic nervous system with vasopressin and renin in the maintenance of blood pressure

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Interaction of Vasopressin and the Baroreceptor Reflex System in the Regulation of Arterial Blood Pressure in the Dog

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Restoration of suppressed baroreflex sensitivity in rats with hereditary diabetes insipidus (Brattleboro rats) by arginine-vasopressin and DDAVP

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin causes endothelium-dependent relaxations of the canine basilar artery

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Differential cardiovascular effects of centrally administered vasopressin in conscious Long Evans and Brattleboro rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Reflex effect of vasopressin after blockade of V1 receptors in the area postrema

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Endothelium-dependent and -independent responses to vasodilators of isolated dog cerebral arteries.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Development and Clinical Application of a New Method for the Radioimmunoassay of Arginine Vasopressin in Human Plasma

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Control of sodium and potassium transport in the cortical collecting duct of the rat. Effects of bradykinin, vasopressin, and deoxycorticosterone

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin V1 receptors on the principal cells of the rabbit cortical collecting tubule. Stimulation of cytosolic free calcium and inositol phosphate production via coupling to a pertussis toxin substrate

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Biphasic forearm vascular responses to intraarterial arginine vasopressin

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Luminal vasopressin modulates transport in the rabbit cortical collecting duct

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Immunohistochemical localization of V2 vasopressin receptor along the nephron and functional role of luminal V2 receptor in terminal inner medullary collecting ducts

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Direct effects of leptin on brown and white adipose tissue

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Information-processing deficits and thought disorder in schizophrenia.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophrenia.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Science review: Vasopressin and the cardiovascular system part 1--receptor physiology

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Clinical review: Vasopressin and terlipressin in septic shock patients

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Terlipressin or europressin?

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin does not mediate hypersensitivity of the hypothalamic pituitary adrenal axis during chronic stress

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Arginine vasopressin (AVP) and AVP-like immunoreactivity in peripheral tissues

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

V1b receptors: new probes for therapy

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of vasopressin V1b receptor deficiency on adrenocorticotropin release from anterior pituitary cells in response to oxytocin stimulation

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin administration into the paraventricular nucleus normalizes plasma oxytocin and corticosterone levels in Brattleboro rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

CENTRAL EFFECTS OF ARGININE VASOPRESSIN ON BLOOD PRESSURE IN RATS

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

A novel type of vasopressin receptor on anterior pituitary corticotrophs?

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of vasopressin on insulin secretion and inositol phosphate production in a hamster beta cell line (HIT).

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Neurohypophyseal Hormone Receptors in the Rat Thymus, Spleen, and Lymphocytes

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The mechanisms underlying the glucose dependence of arginine vasopressin-induced insulin secretion in beta-cells

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Emergence of an isolated arginine vasopressin (AVP) response to stress after repeated restraint: a study of both AVP and corticotropin-releasing hormone messenger ribonucleic acid (RNA) and heteronuclear RNA.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Studies on the mechanism of stimulation of ACTH secretion with the aid of morphine as a blocking agent

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of the Neurohypophysial Hormones on Insulin Secretion

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and cortisol secretion in man.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Oxytocin and Vasopressin V1a and V2 Receptors Form Constitutive Homo- and Heterodimers during Biosynthesis

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The N-terminal juxtamembrane segment of the V1a vasopressin receptor provides two independent epitopes required for high-affinity agonist binding and signaling

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Hypermetabolism of fat in V1a vasopressin receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Heterooligomerization between vasotocin and corticotropin-releasing hormone (CRH) receptors augments CRH-stimulated 3',5'-cyclic adenosine monophosphate production

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

New topics in vasopressin receptors and approach to novel drugs: effects of vasopressin receptor on regulations of hormone secretion and metabolisms of glucose, fat, and protein

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Neural circuitry in the regulation of adrenal corticosterone rhythmicity

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Discontinued psychiatric drugs in 2008.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Patterns of brain vasopressin receptor distribution associated with social organization in microtine rodents

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin increases locomotion through a V1a receptor in orexin/hypocretin neurons: implications for water homeostasis.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin 1b receptor knock-out impairs memory for temporal order

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Elevated serum oxytocin of the vasopressin-deficient Brattleboro rat is present throughout life and is not sensitive to treatment with vasopressin.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Molecular characterization of a cloned human oxytocin receptor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin and oxytocin receptors in the central nervous system.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin stimulates cortisol secretion and phosphoinositide catabolism in cultured bovine adrenal fasciculata/reticularis cells

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin synergistically stimulates DNA synthesis in normal and regenerating rat liver cell cultures in the presence of hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Identification of dimeric and oligomeric complexes of the human oxytocin receptor by co-immunoprecipitation and bioluminescence resonance energy transfer

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Release of aldosterone and corticosterone from the adrenal cortex of the Brattleboro rat in response to administration of ACTH

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin-stimulated insulin secretion and inositol phosphate production: interactions with glucose and phorbol esters

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effect of insulin-induced hypoglycaemia on secretion patterns and rates of corticotrophin-releasing hormone, arginine vasopressin and adrenocorticotrophin in horses

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Congenital vasopressin deficiency and acute and chronic opiate effects on hypothalamo-pituitary-adrenal axis activity in Brattleboro rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin potentiates corticotropin-releasing hormone-induced insulin release from mouse pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Blockade of the V(1b) receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic-pituitary-adrenal axis activity

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Effect of vasopressin 1b receptor blockade on the hypothalamic-pituitary-adrenal response of chronically stressed rats to a heterotypic stressor.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The stimuli-specific role of vasopressin in the hypothalamus-pituitary-adrenal axis response to stress.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Molecular biology of hereditary diabetes insipidus.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Aldosterone requires vasopressin V1a receptors on intercalated cells to mediate acid-base homeostasis

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Critical appraisal and clinical utility of atosiban in the management of preterm labor.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Therapeutic potential of vasopressin receptor antagonists.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

EFFECT OF VASOPRESSIN ON THE RELEASE OF CATECHOLAMINE FROM THE ADRENAL GLAND OF RAT

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Baroreflexive suppression of heat production and fall in body temperature following peripheral administration of vasopressin in rats

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The vasopressin V1b receptor as a therapeutic target in stress-related disorders

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin in liver disease--should we turn on or off?

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Vasopressin : a potent autocrine/paracrine regulator of mammal adrenal functions

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The vasopressin Avpr1b receptor: molecular and pharmacological studies

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Phosphorylation and recycling kinetics of G protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

The role of vasopressin in acute cerebral vasospasm. Effect on spasm of a vasopressin antagonist or vasopressin antiserum

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Evidence for a role of the supraopticohypophyseal system in regulation of adrenocorticotrophin secretion.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Relation between human vasopressin 1a gene variance, fat intake, and diabetes.

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

Acute esophageal variceal bleeding: Current strategies and new perspectives

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00035.2011

7 January 2021

10.1152/PHYSREV.00035.2011

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073632%20AND%20SRC:MED&resulttype=core&format=json